Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Metabolic Disease Research

Background:

• Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine implicated in cardiovascular and metabolic diseases.
• Previous in vitro studies showed TRAIL promotes lipid uptake and foam cell formation in macrophages.
• Clinical data on serum TRAIL concentrations in hypercholesterolemia are inconclusive.

Purpose of the Study:

• To investigate the relationship between serum TRAIL concentration and cholesterol levels in a healthy human cohort.
• To determine if TRAIL levels are associated with hypercholesterolemia.

Main Methods:

• Analysis of serum TRAIL concentration and lipid profiles in 352 generally healthy subjects.
• Statistical correlation analysis between TRAIL levels and total cholesterol, LDL cholesterol, and other metabolic factors.
• Comparison of TRAIL levels in subjects with and without hypercholesterolemia.

Main Results:

• Significant positive correlations were found between serum TRAIL concentration and levels of total cholesterol and low-density lipoprotein (LDL) cholesterol.
• Serum TRAIL levels were significantly elevated in subjects diagnosed with hypercholesterolemia.
• Higher blood cholesterol levels were observed in subjects within the upper quartile of serum TRAIL concentration.

Conclusions:

• Serum TRAIL concentration is elevated in individuals with hypercholesterolemia.
• Elevated TRAIL levels are significantly associated with higher total and LDL cholesterol.
• Further research is warranted to explore the role of TRAIL in the metabolic dysregulation of hypercholesterolemia.